AiMeD expresses dismay over FICCI’s ‘Un-Make in India’ drive
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Cipla has a robust governance model focused on sustainability
The launch of HULIO in the United States is an important milestone for Biocon Biologics
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Subscribe To Our Newsletter & Stay Updated